Human Molecular Genetics, 2002, Vol. 11, No. 22 2787-2792
© 2002 Oxford University Press
Functional association of the parkin gene promoter with idiopathic Parkinson's disease
1Laboratories of Neurogenetics, Department of Neuroscience, Mayo Clinic Jacksonville, Jacksonville, FL 32224, USA, 2Department of Neurology and 3Division of Biostatistics, HSR, Mayo Clinic and Mayo Foundation, Rochester,MN 55905 USA and 4Department of Psychiatry and Behavioral Neurosciences and Molecular Medicine and Genetics, Wayne State University School of Medicine, Detroit, MI 48201, USA
Received July 4, 2002; Accepted August 8, 2002
Loss-of-function mutations in the parkin gene were first identified in autosomal recessive juvenile parkinsonism (AR-JP). Subsequently, parkin mutations were found in many early-onset patients with Parkinson's disease (PD) (<45 years at onset). We hypothesized that parkin gene expression also may contribute to the age-associated risk of idiopathic PD (>50 years at onset). Two single-nucleotide polymorphisms within the parkin core promoter have been identified and assessed. We show one of the variants, -258 T/G, is located in a region of DNA that binds nuclear protein from human substantia nigra in vitro and functionally affects gene transcription. Furthermore, the -258 T/G polymorphism is genetically associated with idiopathic PD, as assessed in a large population-based series of cases and controls. Our results further implicate the parkin gene in the development of Parkinson's disease.
* To whom correspondence should be addressed. Tel: +1 9049530158; Fax: +1 9049537370; Email: farrer.matthew{at}mayo.edu
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
C. Wang, R. Lu, X. Ouyang, M. W. L. Ho, W. Chia, F. Yu, and K.-L. Lim Drosophila Overexpressing Parkin R275W Mutant Exhibits Dopaminergic Neuron Degeneration and Mitochondrial Abnormalities J. Neurosci., August 8, 2007; 27(32): 8563 - 8570. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S. P. Wong, J. M. M. Tan, C. Wang, Z. Zhang, S.-P. Tay, N. Zaiden, H. S. Ko, V. L. Dawson, T. M. Dawson, and K.-L. Lim Relative Sensitivity of Parkin and Other Cysteine-containing Enzymes to Stress-induced Solubility Alterations J. Biol. Chem., April 20, 2007; 282(16): 12310 - 12318. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H.V. Schapira Etiology of Parkinson's disease Neurology, May 23, 2006; 66(10_suppl_4): S10 - S23. [Abstract] [Full Text] |
||||
![]() |
K. M. Rosen, V. Veereshwarayya, C. E-H. Moussa, Q. Fu, M. S. Goldberg, M. G. Schlossmacher, J. Shen, and H. W. Querfurth Parkin Protects against Mitochondrial Toxins and beta-Amyloid Accumulation in Skeletal Muscle Cells J. Biol. Chem., May 5, 2006; 281(18): 12809 - 12816. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Wang, H. S. Ko, B. Thomas, F. Tsang, K. C.M. Chew, S.-P. Tay, M. W.L. Ho, T.-M. Lim, T.-W. Soong, O. Pletnikova, et al. Stress-induced alterations in parkin solubility promote parkin aggregation and compromise parkin's protective function Hum. Mol. Genet., December 15, 2005; 14(24): 3885 - 3897. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Skipper, Y. Li, C. Bonnard, R. Pavanni, Y. Yih, E. Chua, W.-K. Sung, L. Tan, M.-C. Wong, E.-K. Tan, et al. Comprehensive evaluation of common genetic variation within LRRK2 reveals evidence for association with sporadic Parkinson's disease Hum. Mol. Genet., December 1, 2005; 14(23): 3549 - 3556. [Abstract] [Full Text] [PDF] |
||||
![]() |
S M Hague, S Klaffke, and O Bandmann Neurodegenerative disorders: Parkinson's disease and Huntington's disease J. Neurol. Neurosurg. Psychiatry, August 1, 2005; 76(8): 1058 - 1063. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. L. Khan, C. Scherfler, E. Graham, K. P. Bhatia, N. Quinn, A. J. Lees, D. J. Brooks, N. W. Wood, and P. Piccini Dopaminergic dysfunction in unrelated, asymptomatic carriers of a single parkin mutation Neurology, January 11, 2005; 64(1): 134 - 136. [Abstract] [Full Text] [PDF] |
||||
![]() |
D G Healy, P M Abou-Sleiman, E M Valente, W P Gilks, K Bhatia, N Quinn, A J Lees, and N W Wood DJ-1 mutations in Parkinson's disease J. Neurol. Neurosurg. Psychiatry, January 1, 2004; 75(1): 144 - 145. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Eerola, D. Hernandez, J. Launes, O. Hellstrom, S. Hague, C. Gulick, J. Johnson, T. Peuralinna, J. Hardy, P. J. Tienari, et al. Assessment of a DJ-1 (PARK7) polymorphism in Finnish PD Neurology, October 14, 2003; 61(7): 1000 - 1002. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Oliveira, W. K. Scott, M. A. Nance, R. L. Watts, J. P. Hubble, W. C. Koller, K. E. Lyons, R. Pahwa, M. B. Stern, B. C. Hiner, et al. Association Study of Parkin Gene Polymorphisms With Idiopathic Parkinson Disease Arch Neurol, July 1, 2003; 60(7): 975 - 980. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lincoln, J. Wiley, T. Lynch, J. W. Langston, R. Chen, A. Lang, E. Rogaeva, D. S. Sa, R. P. Munhoz, J. Harris, et al. Parkin-proven disease: Common founders but divergent phenotypes Neurology, May 27, 2003; 60(10): 1605 - 1610. [Abstract] [Full Text] [PDF] |
||||





